Allergan, an AbbVie company, announced that the U.S. FDA approved a supplemental Biologics License Application (sBLA) that supports expanded use...
Read moreAstraZeneca and MSD Inc., Kenilworth, N.J., US announced that Lynparza (olaparib) has been approved in the European Union (EU) for...
Read moreAstraZeneca’s heart failure drug Farxiga has picked up a US FDA fast-track designation (FTD) in another indication as it continues...
Read moreBoehringer Ingelheim announced that the EC has approved an additional indication for nintedanib in adults for the treatment of other...
Read moreRB is investing $25 million to set up the Reckitt Global Hygiene Institute (RGHI) which is a research and innovation...
Read moreHeron Therapeutics, a commercial-stage biotechnology company, announced the initiation of the GUARDS-1 Study, a phase 2 clinical study evaluating Cinvanti...
Read moreEli Lilly and Company announced that mirikizumab, an investigational monoclonal antibody that binds to the p19-subunit of IL23, met the...
Read moreGlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research, development, manufacturing and commercialisation of...
Read moreGSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles...
Read moreSanofi and The University of Texas MD Anderson Cancer Center announced a five-year strategic collaboration to accelerate the development of...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.